2023-06-022024-06-302024-06-30false14912217WEPIT HEALTH CARE LTD2025-06-0247990falseiso4217:GBPxbrli:pure149122172023-06-02149122172024-06-30149122172023-06-022024-06-30149122172023-06-01149122172023-06-01149122172023-06-012023-06-0114912217bus:SmallEntities2023-06-022024-06-3014912217bus:AuditExempt-NoAccountantsReport2023-06-022024-06-3014912217bus:FullAccounts2023-06-022024-06-3014912217bus:PrivateLimitedCompanyLtd2023-06-022024-06-3014912217core:WithinOneYear2024-06-3014912217core:AfterOneYear2024-06-3014912217core:WithinOneYear2023-06-0114912217core:AfterOneYear2023-06-0114912217core:ShareCapital2024-06-3014912217core:SharePremium2024-06-3014912217core:RevaluationReserve2024-06-3014912217core:OtherReservesSubtotal2024-06-3014912217core:RetainedEarningsAccumulatedLosses2024-06-3014912217core:ShareCapital2023-06-0114912217core:SharePremium2023-06-0114912217core:RevaluationReserve2023-06-0114912217core:OtherReservesSubtotal2023-06-0114912217core:RetainedEarningsAccumulatedLosses2023-06-0114912217core:LandBuildings2024-06-3014912217core:PlantMachinery2024-06-3014912217core:Vehicles2024-06-3014912217core:FurnitureFittings2024-06-3014912217core:OfficeEquipment2024-06-3014912217core:NetGoodwill2024-06-3014912217core:IntangibleAssetsOtherThanGoodwill2024-06-3014912217core:ListedExchangeTraded2024-06-3014912217core:UnlistedNon-exchangeTraded2024-06-3014912217core:LandBuildings2023-06-0114912217core:PlantMachinery2023-06-0114912217core:Vehicles2023-06-0114912217core:FurnitureFittings2023-06-0114912217core:OfficeEquipment2023-06-0114912217core:NetGoodwill2023-06-0114912217core:IntangibleAssetsOtherThanGoodwill2023-06-0114912217core:ListedExchangeTraded2023-06-0114912217core:UnlistedNon-exchangeTraded2023-06-0114912217core:LandBuildings2023-06-022024-06-3014912217core:PlantMachinery2023-06-022024-06-3014912217core:Vehicles2023-06-022024-06-3014912217core:FurnitureFittings2023-06-022024-06-3014912217core:OfficeEquipment2023-06-022024-06-3014912217core:NetGoodwill2023-06-022024-06-3014912217core:IntangibleAssetsOtherThanGoodwill2023-06-022024-06-3014912217core:ListedExchangeTraded2023-06-022024-06-3014912217core:UnlistedNon-exchangeTraded2023-06-022024-06-3014912217core:MoreThanFiveYears2023-06-022024-06-3014912217core:Non-currentFinancialInstruments2024-06-3014912217core:Non-currentFinancialInstruments2023-06-0114912217dpl:CostSales2023-06-022024-06-3014912217dpl:DistributionCosts2023-06-022024-06-3014912217core:LandBuildings2023-06-022024-06-3014912217core:PlantMachinery2023-06-022024-06-3014912217core:Vehicles2023-06-022024-06-3014912217core:FurnitureFittings2023-06-022024-06-3014912217core:OfficeEquipment2023-06-022024-06-3014912217dpl:AdministrativeExpenses2023-06-022024-06-3014912217core:NetGoodwill2023-06-022024-06-3014912217core:IntangibleAssetsOtherThanGoodwill2023-06-022024-06-3014912217dpl:GroupUndertakings2023-06-022024-06-3014912217dpl:ParticipatingInterests2023-06-022024-06-3014912217dpl:GroupUndertakingscore:ListedExchangeTraded2023-06-022024-06-3014912217core:ListedExchangeTraded2023-06-022024-06-3014912217dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-06-022024-06-3014912217core:UnlistedNon-exchangeTraded2023-06-022024-06-3014912217dpl:CostSales2023-06-012023-06-0114912217dpl:DistributionCosts2023-06-012023-06-0114912217core:LandBuildings2023-06-012023-06-0114912217core:PlantMachinery2023-06-012023-06-0114912217core:Vehicles2023-06-012023-06-0114912217core:FurnitureFittings2023-06-012023-06-0114912217core:OfficeEquipment2023-06-012023-06-0114912217dpl:AdministrativeExpenses2023-06-012023-06-0114912217core:NetGoodwill2023-06-012023-06-0114912217core:IntangibleAssetsOtherThanGoodwill2023-06-012023-06-0114912217dpl:GroupUndertakings2023-06-012023-06-0114912217dpl:ParticipatingInterests2023-06-012023-06-0114912217dpl:GroupUndertakingscore:ListedExchangeTraded2023-06-012023-06-0114912217core:ListedExchangeTraded2023-06-012023-06-0114912217dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-06-012023-06-0114912217core:UnlistedNon-exchangeTraded2023-06-012023-06-0114912217core:NetGoodwill2024-06-3014912217core:IntangibleAssetsOtherThanGoodwill2024-06-3014912217core:LandBuildings2024-06-3014912217core:PlantMachinery2024-06-3014912217core:Vehicles2024-06-3014912217core:FurnitureFittings2024-06-3014912217core:OfficeEquipment2024-06-3014912217core:AfterOneYear2024-06-3014912217core:WithinOneYear2024-06-3014912217core:ListedExchangeTraded2024-06-3014912217core:UnlistedNon-exchangeTraded2024-06-3014912217core:ShareCapital2024-06-3014912217core:SharePremium2024-06-3014912217core:RevaluationReserve2024-06-3014912217core:OtherReservesSubtotal2024-06-3014912217core:RetainedEarningsAccumulatedLosses2024-06-3014912217core:NetGoodwill2023-06-0114912217core:IntangibleAssetsOtherThanGoodwill2023-06-0114912217core:LandBuildings2023-06-0114912217core:PlantMachinery2023-06-0114912217core:Vehicles2023-06-0114912217core:FurnitureFittings2023-06-0114912217core:OfficeEquipment2023-06-0114912217core:AfterOneYear2023-06-0114912217core:WithinOneYear2023-06-0114912217core:ListedExchangeTraded2023-06-0114912217core:UnlistedNon-exchangeTraded2023-06-0114912217core:ShareCapital2023-06-0114912217core:SharePremium2023-06-0114912217core:RevaluationReserve2023-06-0114912217core:OtherReservesSubtotal2023-06-0114912217core:RetainedEarningsAccumulatedLosses2023-06-0114912217core:NetGoodwill2023-06-0114912217core:IntangibleAssetsOtherThanGoodwill2023-06-0114912217core:LandBuildings2023-06-0114912217core:PlantMachinery2023-06-0114912217core:Vehicles2023-06-0114912217core:FurnitureFittings2023-06-0114912217core:OfficeEquipment2023-06-0114912217core:AfterOneYear2023-06-0114912217core:WithinOneYear2023-06-0114912217core:ListedExchangeTraded2023-06-0114912217core:UnlistedNon-exchangeTraded2023-06-0114912217core:ShareCapital2023-06-0114912217core:SharePremium2023-06-0114912217core:RevaluationReserve2023-06-0114912217core:OtherReservesSubtotal2023-06-0114912217core:RetainedEarningsAccumulatedLosses2023-06-0114912217core:AfterOneYear2023-06-022024-06-3014912217core:WithinOneYear2023-06-022024-06-3014912217core:Non-currentFinancialInstrumentscore:CostValuation2023-06-022024-06-3014912217core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-022024-06-3014912217core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-022024-06-3014912217core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-022024-06-3014912217core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-022024-06-3014912217core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-022024-06-3014912217core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-022024-06-3014912217core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-022024-06-3014912217core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-022024-06-3014912217core:Non-currentFinancialInstrumentscore:CostValuation2024-06-3014912217core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-06-3014912217core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-06-3014912217core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-06-3014912217core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-06-3014912217core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-06-3014912217core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-06-3014912217core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-06-3014912217core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-06-3014912217core:Non-currentFinancialInstrumentscore:CostValuation2023-06-0114912217core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-0114912217core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-0114912217core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-0114912217core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-0114912217core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-0114912217core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-0114912217core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-0114912217core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-0114912217bus:Director12023-06-022024-06-30

WEPIT HEALTH CARE LTD

Registered Number
14912217
(England and Wales)

Unaudited Financial Statements for the Period ended
30 June 2024

WEPIT HEALTH CARE LTD
Company Information
for the period from 2 June 2023 to 30 June 2024

Director

ELLIS, Walford

Registered Address

42 A Newington High Street
Kent
Newington
ME9 7JL

Registered Number

14912217 (England and Wales)
WEPIT HEALTH CARE LTD
Balance Sheet as at
30 June 2024

Notes

2024

£

£

Fixed assets
Tangible assets3225
225
Current assets
Stocks43,550
Debtors2,004
Cash at bank and on hand1,000
6,554
Creditors amounts falling due within one year5(7,886)
Net current assets (liabilities)(1,332)
Total assets less current liabilities(1,107)
Net assets(1,107)
Capital and reserves
Called up share capital1
Profit and loss account(1,108)
Shareholders' funds(1,107)
The financial statements were approved and authorised for issue by the Director on 2 June 2025, and are signed on its behalf by:
ELLIS, Walford
Director
Registered Company No. 14912217
WEPIT HEALTH CARE LTD
Notes to the Financial Statements
for the period ended 30 June 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
2.Average number of employees

2024
Average number of employees during the year1
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
Additions300300
At 30 June 24300300
Depreciation and impairment
Charge for year7575
At 30 June 247575
Net book value
At 30 June 24225225
At 01 June 23--
4.Stocks
Stocks comprise finished goods, bought for resale, stated at cost.

2024

£
Finished goods3,550
Total3,550
5.Creditors: amounts due within one year

2024

£
Other creditors7,886
Total7,886